Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02998892 · ClinicalTrials.gov registry record · NA

Effects of Microbouts of Activity on Metabolic Health

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT02998892: Completed NA study, sponsored by University of Colorado, Denver.

NCT02998892 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02998892, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Population studies suggest that time spent in sedentary behaviors is associated with all-cause mortality including obesity, diabetes, and cardiovascular diseases, independent of time spent in exercise. Frequent interruptions to sedentary time are however beneficially associated with metabolic health outcomes, even in individuals who exercise regularly. The goal is to use integrative approach to understand the biological mechanisms that underlie these associations in a longitudinal intervention study in overweight sedentary adults. The investigators believe that the proposed study will provide an initial evidence base for the health benefits of breaking up prolonged sitting with short bursts of activity. This innovative strategy may be more effective at combating the adverse effects of sedentary behaviors than more traditional approaches.

Primary Outcome

Over each 2 week period, participants will be instructed to wear an ActiPAL (PALTechnologies: Glasgow, Scotland) activity monitor on their right leg. Participants will be instructed to wear the monitors at all times except when sleeping or participating in water-based activities. The time-stamped "event" data file from the activPAL software will be used to determine time spent sitting/lying, standing and stepping per day.

Interventions

  • BEHAVIORAL Traditional Exercise Training
  • BEHAVIORAL Daily Microbursts of Activity

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-05-09
Est. Completion 2021-10-08
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT02998892 record still lists

NCT02998892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Traditional Exercise Training is the first listed.

NCT02998892 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02998892 about?

NCT02998892 is a clinical study titled "Effects of Microbouts of Activity on Metabolic Health". Population studies suggest that time spent in sedentary behaviors is associated with all-cause mortality including obesity, diabetes, and cardiovascular diseases, independent of time spent in exercise. Frequent interruptions to sedentary time are however beneficially associated with metabolic health...

What is the current status of trial NCT02998892?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-05-09. Estimated completion is 2021-10-08.

What interventions are being tested in trial NCT02998892?

The interventions under investigation include: Traditional Exercise Training (BEHAVIORAL), Daily Microbursts of Activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT02998892?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02998892's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02998892, the US trial registry maintained by the National Library of Medicine. NCT02998892 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.